CJC-1295 (no DAC) + Ipamorelin
Also known as: CJC-1295/ipamorelin · CJC/Ipa · CJC ipa blend · Mod GRF 1-29 + ipamorelin
Updated 19 sources
Quick facts
- Half-life
- Ipamorelin: about 2 hours after IV dosing. CJC-1295 no DAC: about 30 minutes per guides, never measured in humans.
- Routes
- Subcutaneous injection
- Reported dose ranges
- 100 to 400 mcg (subcutaneous injection)
- 100 to 500 mcg (subcutaneous injection)
- Vial sizes
- 10 mg
- FDA status
- Not FDA approved
- WADA
- Prohibited
- In each vial
- CJC-1295 5 mg + Ipamorelin 5 mg
What people use CJC-1295 (no DAC) + Ipamorelin for
- Deeper sleep with a bedtime shot
- Training recovery
- Body recomposition
- General GH optimization, often dosed after strength training
How it is thought to work. Two receptors, one pulse. CJC-1295 without DAC is a GHRH analog: it tells the pituitary to release a bigger GH pulse. Ipamorelin binds the ghrelin receptor and starts the pulse. In human studies of related peptides, a GHRP plus GHRH released more GH together than either alone. That synergy is the whole case for the pair; it has not been tested with these two peptides specifically.
CJC-1295 (no DAC) + Ipamorelin dosing
Pre-mixed blend2
Pre-mixed blend, total blend per day (1:1)
Other protocols: injected6
Classic bedtime shot (amount is per peptide)
Timing and details
Loading…
Forum convention (CJC amount; ipamorelin paired)
Timing and details
Loading…
Self-logged CJC no-DAC doses
Timing and details
Loading…
Stack guide range (amount is per peptide)
Timing and details
Loading…
Three times a day (amount is per peptide)
Timing and details
Loading…
Conservative cycle (amount is per peptide)
Doses shown are what sources report, labelled by origin. Not medical advice.
Full CJC-1295 (no DAC) + Ipamorelin dosage guideEvery titration step in syringe units, missed doses and how to mix.Vial strengths and syringe units
| Water | Strength | 100 mcgof CJC-1295, units | 200 mcgof CJC-1295, units | 300 mcgtotal blend, units |
|---|---|---|---|---|
| 10 mg vial | ||||
| 2 mLCompetitor guide | 5 mg/mL | 40.04 mL | 80.08 mL | 60.06 mL |
| 3 mLCompetitor guide | 3.333 mg/mL | 60.06 mL | 120.12 mL | 90.09 mL |
| Component | Per vial | 100 mcg of CJC-1295 | 200 mcg of CJC-1295 | 300 mcg total blend |
|---|---|---|---|---|
| CJC-1295 | 5 mg | 100 mcg | 200 mcg | 150 mcg |
| Ipamorelin | 5 mg | 100 mcg | 200 mcg | 150 mcg |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: CJC-1295 (no DAC) + Ipamorelin in syringe units, with the math shown.What people report
Community-reportedFrom 900 Reddit posts and comments, last mined Oct 23, 2026r/Peptides, r/Biohackers, r/Peptidesource, r/PeptideDiscussion
Doses people report for CJC-1295 (no DAC) + Ipamorelin
Goal not stated51 mentions
| Reported | Mentions |
|---|---|
| 100 mcg | 8 |
| 200 mcg | 8 |
| 250 mcg | 7 |
| 300 mcg | 5 |
| 400 mcg | 3 |
Sleep7 mentions
| Reported | Mentions |
|---|---|
| 250 mcg | 2 |
| 300 mcg | 2 |
Muscle growth3 mentions
| Reported | Mentions |
|---|---|
| 300 mcg | 2 |
Left out: 8 mentions given in syringe units, which mean different doses in different mixes.
How often
| Reported | Mentions |
|---|---|
| Once a day | 22 |
| 5 days on, 2 off | 9 |
| Twice a day | 4 |
Most mentioned alongside
Side effects people mention
Flushing21 mentions
Most common fixes: none (3), lower the dose (3)
Fast heart rate13 mentions
Most common fixes: none (2), switch to morning administration (2)
Poor sleep11 mentions
Most common fix: switch to morning administration (4)
Hives8 mentions
Most common fix: discontinue use (2)
Water retention7 mentions
Most common fix: discontinue use (2)
Improved sleep7 mentions
Doses shown are what sources report, labelled by origin. Not medical advice.
CJC-1295 (no DAC) + Ipamorelin side effects
Reported by users and guides6
From community reports and dosing guides. Not measured rates.
Flushing or warmth after the shot
Guides report it in the first minutes after injection, mostly in weeks 1 to 2
Water retention
Guides report it in the first 2 to 3 weeks, settling by week 3 to 4. One guide says 10 to 30% of users, with no source for that figure
How people manage it
- Keep carbs moderate, per one stack guide.
Tingling or numbness in the hands
Guides read it as a sign GH is running high
How people manage it
- One guide cuts ipamorelin by 25 to 50 mcg. With a fixed 1:1 blend you can only lower both together.
Hunger
Reported by guides
Headache
Guides report mild headaches in weeks 1 to 2
Injection-site irritation or numbness
Reported by guides
How people manage it
- Rotate sites between the lower abdomen and thighs.
Storage
Powder (before mixing)
- Temperature
- 2 to 8 °C
Keep the powder in the fridge at 2 to 8 °C. One guide says room temperature is fine short term if kept away from light.
Mixed vial
- Temperature
- 2 to 8 °C
- Use within
- 28 days
Fridge, 2 to 8 °C. Guides give 28 to 30 days for the blend. One gives 20 days for CJC no-DAC on its own. Swirl, never shake.
Mixed with: Bacteriostatic water
Mixing. The 10 mg blend is 5 mg CJC-1295 no DAC plus 5 mg ipamorelin. 2 mL is the most common volume; 3 mL gives smaller amounts per unit. With separate vials, guides add 2 mL to each 5 mg vial and draw CJC first, then ipamorelin into the same syringe. Swirl gently, do not shake. A 2 mg/2 mg blend was not found in the sources.
Stacks people report
Added for recovery, with BPC-157 at 250 mcg and TB-500 alongside.
Added for injury recovery together with BPC-157.
- Mk 677
Taken at night for a steadier GH baseline, according to community accounts quoted by a guide.
Swapped in for CJC-1295 when the goal is visceral fat, since tesamorelin has Phase 3 visceral-fat data.
Compare CJC-1295 (no DAC) + Ipamorelin
Evidence and legal status
Evidence: no human trials
No trial of this combination exists, and CJC-1295 no DAC is essentially uncharacterized in humans; its claims are extrapolated from sermorelin. Ipamorelin was well tolerated in a short IV surgery trial. CJC-1295 with DAC showed no serious adverse reactions in healthy adults. In older adults a low GHRP-2 dose amplified the GH response to GHRH, which is the logic behind pairing.
FDA and WADA
An approval withdrawn, or removed from FDA's compounding lists.
Neither peptide is FDA approved. CJC-1295 sits in FDA's table of withdrawn compounding nominations with increased heart rate noted. Ipamorelin acetate is in 503B Category 2.
WADA 2026 bans both at all times under S2.2.4: CJC-1295 as a GHRH analogue, ipamorelin as a GH secretagogue.
WADA: Prohibited
CJC-1295 (no DAC) + Ipamorelin questions
How much CJC-1295 and ipamorelin per day?
The most common shot is 100 mcg of each, 1 to 3 times a day. Guides range up to 200 mcg CJC and 300 mcg ipamorelin per shot.
How much water do I add to a 10 mg blend?
2 mL is the usual choice and gives 5 mg/mL total, which is 2.5 mg/mL of each peptide. Some guides use 3 mL. Use the blend calculator to turn your dose into syringe units.
Is a 10 mg blend 10 mg of each peptide?
No. It is 5 mg CJC-1295 no DAC plus 5 mg ipamorelin. Getting this wrong doubles your math.
When should I inject it?
Before bed on an empty stomach is the anchor shot. A second shot in the morning, fasted, is optional. Guides want food out of the way for 1 to 2 hours because it blunts the pulse.
Can I mix both in one syringe?
Yes, according to guides. With separate vials, draw CJC first, then ipamorelin on top.
Can I run more ipamorelin than CJC?
Not with a 1:1 blend, because every draw takes both in the same ratio. Guides that run 100 mcg CJC with 200 to 300 mcg ipamorelin use separate vials.
DAC or no DAC for this stack?
Blends use CJC-1295 without DAC. The DAC version is a separate, week-long product.
How long do people run it?
8 to 16 weeks, then 4 to 8 weeks off, per guides. Forum protocols run 12 to 16 weeks with 4 to 6 off. Some guides use 5 days on and 2 off each week.
Should I start with both at once?
One guide starts with ipamorelin alone for the first week, then adds CJC. Another simply starts at 100 mcg per injection.
Why are my hands tingling?
Guides read hand tingling as a sign GH is running high and lower the dose.
Is there clinical evidence for this combination?
No. No trial has tested CJC-1295 no DAC with ipamorelin, and CJC-1295 no DAC has not been characterized in humans. Ipamorelin has short IV studies; the DAC version of CJC-1295 has Phase 1 and 2 data.
Is it allowed in sport?
No. WADA bans both peptides at all times under S2.
Ask about CJC-1295 (no DAC) + Ipamorelin
Answers come from this site's pages only, with a link to each source.
Sources
19 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study3
- CJC-1295 in healthy adults (Teichman 2006)PubMed · checked Oct 23, 2026
- Tesamorelin pooled Phase 3 (Falutz 2010)PubMed · checked Oct 23, 2026
- Ipamorelin PK-PD (Gobburu 1999)PubMed · checked Oct 23, 2026
Regulatory2
- Certain bulk drug substances, safety risksFDA · checked Oct 23, 2026
- WADA Prohibited List 2026WADA · checked Oct 23, 2026
Competitor guide12
- CJC-1295 / ipamorelin protocolPathToPeptides · checked Oct 23, 2026
- How to reconstitute CJC-1295 + ipamorelinPeptidesExplorer · checked Oct 23, 2026
- CJC-1295 no DAC + ipamorelin 10 mg blendPeptideDosages · checked Oct 23, 2026
Community-reported2
- Performance-enhancing peptides modulating GH-IGF1 axis (Dominikowski 2026)PMC · checked Oct 23, 2026
- CJC-1295 (no DAC) self-logged dosesPeptIQ · checked Oct 23, 2026